Mechanisms for industry input on FDA guidance agenda suggested in comments.
This article was originally published in The Gray Sheet
GUIDANCE DOCUMENT "CALENDAR" COULD PROVIDE OPPORTUNITY FOR INDUSTRY PROPOSALS for FDA guidance documents, in addition to listing the agency's guidance development plans, Steris says in recent comments on FDA's good guidance practices proposal ("The Gray Sheet" March 11, I&W-3). The calendar "would list all planned guidance document activities, including all opportunities for written and oral comments, and would allow members of the public to propose guidance document topics," the sterilizer company suggests. FDA or an industry committee "may need to loosely filter" the proposals "to avoid an explosion of meritless calendar listings," Steris adds.
You may also be interested in...
The leading Korean pharma firm’s oral, third-generation EGFR-TKI is approved in the country, providing a new option for patients with advanced NSCLC and increasing hopes for global approvals given an ongoing global Phase III combination trial led by partner J&J.
DePuy Synthes expects its Velys robotic-assisted system to be cost-effective, easy-to-use and to be well-suited for use in ambulatory surgery centers.
The US FDA wants manufacturers and compounding facilities to test drug products for methanol in alcohol ingredients, and responds to reports of fatal methanol poisonings of consumers who ingested alcohol-based based hand sanitizers.